Customized platelet-rich plasma with transforming growth factor β1 neutralization antibody to reduce fibrosis in skeletal muscle

Biomaterials

Volumn 87, Issue , 2016, Pages 147-156

  Li, Hongshuai ^a   Hicks, Justin J ^a   Wang, Ling ^a   Oyster, Nick ^a   Philippon, Marc J ^b   Hurwitz, Shepard ^c   Hogan, MaCalus V ^a   Huard, Johnny ^b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b STEADMAN PHILIPPON RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Fibrosis; Muscle injury; Neutralization; Platelet rich plasma; TGF Beta 1

Indexed keywords

ANTIBODIES; ENZYME INHIBITION; MACROPHAGES; MUSCULOSKELETAL SYSTEM; NEURONS; PLASMA (HUMAN); PLATELETS; REPAIR;

FIBROSIS; MUSCLE INJURIES; NEUTRALIZATION; PLATELET RICH PLASMA; TGF-BETA 1;

MUSCLE;

CARDIOTOXIN; COLLAGEN; NEUTRALIZING ANTIBODY; TRANSCRIPTION FACTOR PAX7; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; MACROPHAGE; MALE; MUSCLE INJURY; MUSCLE REGENERATION; MYOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; THROMBOCYTE RICH PLASMA; ANIMAL; ANTAGONISTS AND INHIBITORS; FIBROSIS; FISCHER 344 RAT; IMMUNOLOGY; INJURIES; MUSCULAR DISEASES; PATHOLOGY; REGENERATION; VASCULARIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; FIBROSIS; MALE; MUSCLE, SKELETAL; MUSCULAR DISEASES; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-RICH PLASMA; RATS, INBRED F344; REGENERATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84958973004     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.02.017     Document Type: Article

References (62)

1. Huard J, Li Y, Fu FH Muscle injuries and repair: current trends in research. J. Bone Jt. Surg. Am. 2002, 84-A(5):822-832.
2. Baoge L., Van Den Steen E., Rimbaut S., Philips N., Witvrouw E., Almqvist K.F., et al. Treatment of skeletal muscle injury: a review. ISRN Orthop. 2012, 2012:689012.
3. MS AH, Mohamed Ali MR, Yusof A, George J, Lee LP Platelet-rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial. Am. J. Sports Med. 2014, 42(10):2410-2418.
4. Engebretsen L., Steffen K., Alsousou J., Anitua E., Bachl N., Devilee R., et al. IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br. J. Sports Med. 2010, 44:1072-1081.
5. Li H., Usas A., Poddar M., Chen C.W., Thompson S., Ahani B., et al. Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness. PLoS One 2013, 8:e64923.
6. Border W.A., Noble N.A. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 1994, 331:1286-1292.
7. Florini J.R., Ewton D.Z., Magri K.A. Hormones, growth factors, and myogenic differentiation. Annu. Rev. Physiol 1991, 53:201-216.
8. Liu D., Black B.L., Derynck R. TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 2001, 15:2950-2966.
9. Ignotz R.A., Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 1986, 261:4337-4345.
10. Rothan H.A., Djordjevic I., Bahrani H., Paydar M., Ibrahim F., Rahmanh N.A., et al. Three-dimensional culture environment increases the efficacy of platelet rich plasma releasate in prompting skin fibroblast differentiation and extracellular matrix formation. Int. J. Med. Sci. 2014, 11:1029-1038.
11. Delos D., Leineweber M.J., Chaudhury S., Alzoobaee S., Gao Y., Rodeo S.A. The effect of platelet-rich plasma on muscle contusion healing in a rat model. Am. J. Sports Med. 2014, 42:2067-2074.
12. Terada S., Ota S., Kobayashi M., Kobayashi T., Mifune Y., Takayama K., et al. Use of an antifibrotic agent improves the effect of platelet-rich plasma on muscle healing after injury. J. Bone Jt. Surg. Am. 2013, 95:980-988.
13. Anitua E., Troya M., Orive G. Plasma rich in growth factors promote gingival tissue regeneration by stimulating fibroblast proliferation and migration and by blocking transforming growth factor-beta1-induced myodifferentiation. J. Periodontol. 2012, 83:1028-1037.
14. Anitua E., Sanchez M., Merayo-Lloves J., De la Fuente M., Muruzabal F., Orive G. Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-induced myodifferentiation. Invest. Ophthalmol. Vis. Sci. 2011, 52:6066-6073.
15. Li H, Li B PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP. J. Vis. Exp. 2013, 74.
16. Kojima A., Goto K., Morioka S., Naito T., Akema T., Fujiya H., et al. Heat stress facilitates the regeneration of injured skeletal muscle in rats. J. Orthop. Sci. Off. J. Jpn. Orthop. Assoc. 2007, 12:74-82.
17. Hurme T., Kalimo H. Activation of myogenic precursor cells after muscle injury. Med. Sci. Sports Exerc. 1992, 24:197-205.
18. Foster W., Li Y., Usas A., Somogyi G., Huard J. Gamma interferon as an antifibrosis agent in skeletal muscle. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 2003, 21:798-804.
19. Nozaki M., Li Y., Zhu J., Ambrosio F., Uehara K., Fu F.H., et al. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. Am. J. Sports Med. 2008, 36:2354-2362.
20. Ota S., Uehara K., Nozaki M., Kobayashi T., Terada S., Tobita K., et al. Intramuscular transplantation of muscle-derived stem cells accelerates skeletal muscle healing after contusion injury via enhancement of angiogenesis. Am. J. Sports Med. 2011, 39:1912-1922.
21. Kasemkijwattana C., Menetrey J., Somogyl G., Moreland M.S., Fu F.H., Buranapanitkit B., et al. Development of approaches to improve the healing following muscle contusion. Cell Transplant. 1998, 7:585-598.
22. Mifune Y., Matsumoto T., Takayama K., Ota S., Li H., Meszaros L.B., et al. The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair. Osteoarthr. Cartil. 2013, 21:175-185.
23. Miyata Y., Sagara Y., Watanabe S., Asai A., Matsuo T., Ohba K., et al. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34. Virchows Archiv. Int. J. Pathol. 2013, 463:673-679.
24. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
25. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11:723-737.
26. Martinez F.O., Helming L., Milde R., Varin A., Melgert B.N., Draijer C., et al. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood 2013, 121:e57-69.
27. Hamilton B Medical management of hamstring muscle injury: strained evidence for platelet rich plasma. Br. J. Sports Med. 2014, 48(18):1336.
28. Reurink G., Goudswaard G.J., Moen M.H., Weir A., Verhaar J.A., Bierma-Zeinstra S.M., et al. Platelet-rich plasma injections in acute muscle injury. N. Engl. J. Med. 2014, 370:2546-2547.
29. Moraes V.Y., Lenza M., Tamaoki M.J., Faloppa F., Belloti J.C. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane database Syst. Rev. 2014, 4. CD010071.
30. Moraes V.Y., Lenza M., Tamaoki M.J., Faloppa F., Belloti J.C. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane database Syst. Rev. 2013, 12. CD010071.
31. Kelc R., Vogrin M. Concerns about fibrosis development after scaffolded PRP therapy of muscle injuries: commentary on an article by Sanchez et al.: "Muscle repair: platelet-rich plasma derivates as a bridge from spontaneity to intervention. Injury 2015, 46:428.
32. Kushida S., Kakudo N., Suzuki K., Kusumoto K. Effects of platelet-rich plasma on proliferation and myofibroblastic differentiation in human dermal fibroblasts. Ann. Plast. Surg. 2013, 71:219-224.
33. Caceres M., Hidalgo R., Sanz A., Martinez J., Riera P., Smith P.C. Effect of platelet-rich plasma on cell adhesion, cell migration, and myofibroblastic differentiation in human gingival fibroblasts. J. Periodontol. 2008, 79:714-720.
34. Caceres M., Martinez C., Martinez J., Smith P.C. Effects of platelet-rich and -poor plasma on the reparative response of gingival fibroblasts. Clin. Oral Implants Res. 2012, 23:1104-1111.
35. Anitua E., Prado R., Orive G. Platelet-rich plasma and myofibroblasts: is the composition the key to success?. Adv. Skin Wound Care 2015, 28:198-199.
36. Mann C.J., Perdiguero E., Kharraz Y., Aguilar S., Pessina P., Serrano A.L., et al. Aberrant repair and fibrosis development in skeletal muscle. Skelet. Muscle 2011, 1:21.
37. Dimauro I., Grasso L., Fittipaldi S., Fantini C., Mercatelli N., Racca S., et al. Platelet-rich plasma and skeletal muscle healing: a molecular analysis of the early phases of the regeneration process in an experimental animal model. PLoS One 2014, 9:e102993.
38. Hawke T.J., Garry D.J. Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol 2001, 91:534-551.
39. Charge S.B., Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 2004, 84:209-238.
40. Allen R.E., Boxhorn L.K. Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J. Cell. Physiol 1989, 138:311-315.
41. Florini J.R., Ewton D.Z., Coolican S.A. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 1996, 17:481-517.
42. Andia I., Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat. Rev. Rheumatol. 2013, 9:721-730.
43. Sohn D.H., Sokolove J., Sharpe O., Erhart J.C., Chandra P.E., Lahey L.J., et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res. Ther. 2012, 14:R7.
44. Montaseri A., Busch F., Mobasheri A., Buhrmann C., Aldinger C., Rad J.S., et al. IGF-1 and PDGF-bb suppress IL-1beta-induced cartilage degradation through down-regulation of NF-kappaB signaling: involvement of Src/PI-3K/AKT pathway. PLoS One 2011, 6:e28663.
45. Coudriet G.M., He J., Trucco M., Mars W.M., Piganelli J.D. Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases. PLoS One 2010, 5:e15384.
46. Chen W.H., Lo W.C., Hsu W.C., Wei H.J., Liu H.Y., Lee C.H., et al. Synergistic anabolic actions of hyaluronic acid and platelet-rich plasma on cartilage regeneration in osteoarthritis therapy. Biomaterials 2014, 35:9599-9607.
47. Gobbi A, Lad D, Karnatzikos G The effects of repeated intra-articular PRP injections on clinical outcomes of early osteoarthritis of the knee. Knee Surg. Sports Traumatol. Arthrosc. Off. J. ESSKA 2015, 23(8):2170-2177.
48. Bendinelli P., Matteucci E., Dogliotti G., Corsi M.M., Banfi G., Maroni P., et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kappaB inhibition via HGF. J. Cell. Physiol 2010, 225:757-766.
49. van Buul G.M., Koevoet W.L., Kops N., Bos P.K., Verhaar J.A., Weinans H., et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am. J. Sports Med. 2011, 39:2362-2370.
50. Anitua E., Sanchez M., Nurden A.T., Zalduendo M.M., de la Fuente M., Azofra J., et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology 2007, 46:1769-1772.
51. Anitua E., Sanchez M., Zalduendo M.M., de la Fuente M., Prado R., Orive G., et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif. 2009, 42:162-170.
52. Finnson K.W., McLean S., Di Guglielmo G.M., Philip A. Dynamics of transforming growth factor beta signaling in wound healing and scarring. Adv. Wound Care 2013, 2:195-214.
53. Wang X.J., Han G., Owens P., Siddiqui Y., Li A.G. Role of TGF beta-mediated inflammation in cutaneous wound healing. J. Invest. Dermatol. Symp. Proceed. Soc. Invest. Dermatol. Inc Eur. Soc. Dermatol. Res. 2006, 11:112-117.
54. Shen W., Li Y., Zhu J., Schwendener R., Huard J. Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury. J. Cell. Physiol. 2008, 214:405-412.
55. Gong D., Shi W., Yi S.J., Chen H., Groffen J., Heisterkamp N. TGFbeta signaling plays a critical role in promoting alternative macrophage activation. BMC Immunol. 2012, 13:31.
56. Novak M.L., Koh T.J. Phenotypic transitions of macrophages orchestrate tissue repair. Am. J. Pathol. 2013, 183:1352-1363.
57. Gleissner C.A., Shaked I., Little K.M., Ley K. CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J. Immunol. 2010, 184:4810-4818.
58. Vasina E.M., Cauwenberghs S., Feijge M.A., Heemskerk J.W., Weber C., Koenen R.R. Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis. 2011, 2:e211.
59. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 2005, 115:56-65.
60. Pesce J.T., Ramalingam T.R., Mentink-Kane M.M., Wilson M.S., El Kasmi K.C., Smith A.M., et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009, 5:e1000371.
61. Pesce J.T., Ramalingam T.R., Wilson M.S., Mentink-Kane M.M., Thompson R.W., Cheever A.W., et al. Retnla (relmalpha/fizz1) suppresses helminth-induced Th2-type immunity. PLoS Pathog. 2009, 5:e1000393.
62. Wilson M.S., Elnekave E., Mentink-Kane M.M., Hodges M.G., Pesce J.T., Ramalingam T.R., et al. IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J. Clin. Invest. 2007, 117:2941-2951.